银诺医药-B(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02591 银诺医药-B

未开盘 02-06 16:08:02

26.840

-0.100

-0.37%

最高27.360	最低25.900	成交量55.36万
今开26.900	昨收26.940	日振幅5.42%
总市值122.66亿	流通市值112.80亿	总股本4.57亿
成交额1,481万	换手率0.13%	流通股本4.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"银诺医药-B","latestPrice":26.84,"timestamp":1770365282568,"preClose":26.94,"halted":0,"volume":553600,"delay":0,"changeRate":-0.003711952487008219,"floatShares":420285370,"shares":457000000,"eps":-0.416279,"marketStatus":"未开盘","change":-0.1,"latestTime":"02-06 16:08:02","open":26.9,"high":27.36,"low":25.9,"amount":14807020,"amplitude":0.054195,"askPrice":27,"askSize":200,"bidPrice":26.84,"bidSize":1800,"shortable":0,"etf":0,"ttmEps":-0.533,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":0,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":26.94,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":0.3110706539398918,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02591/tweets","defaultTab":"tweets","newsList":[{"id":"2609563048","title":"银诺医药-B(02591)：杨东妍获委任为联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2609563048","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609563048?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:41","pubTimestamp":1770367311,"startTime":"0","endTime":"0","summary":"智通财经APP讯，银诺医药-B(02591)发布公告，金今女士因个人发展原因辞任公司联席公司秘书，自2026年2月6日起生效。杨东妍女士已获委任为联席公司秘书，自2026年2月6日起生效。杨女士将与另一名现任联席公司秘书施雪玲女士共同履行公司秘书职务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"1140982312","title":"港股异动 | 银诺医药涨超16%，公司核心产品依苏帕格鲁肽α在宠物糖尿病管理已取得积极进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1140982312","media":"老虎资讯综合","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140982312?lang=zh_cn&edition=full","pubTime":"2026-02-05 09:51","pubTimestamp":1770256294,"startTime":"0","endTime":"0","summary":"2月5日，$银诺医药-B$涨超16%，公司核心产品依苏帕格鲁肽α在宠物糖尿病管理已取得积极进展。消息面上，银诺医药-B发布公告，于2026年2月4日，公司核心产品依苏帕格鲁肽α用于治疗宠物糖尿病的新兽药临床试验申请已获中华人民共和国农业农村部正式受理。根据临床前试验结果，就疗效和安全性而言，依苏帕格鲁肽α在宠物糖尿病管理方面已取得积极进展，可为后续开展该药物相关的临床试验和注册申请提供合理依据。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"059ce91f94e1e421008ab9104b6318dc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2608636075","title":"银诺医药-B(02591)：依苏帕格鲁肽α的新兽药临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2608636075","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608636075?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:20","pubTimestamp":1770214850,"startTime":"0","endTime":"0","summary":"智通财经APP讯，银诺医药-B 发布公告，于2026年2月4日，公司核心产品依苏帕格鲁肽α用于治疗宠物糖尿病的新兽药临床试验申请已获中华人民共和国农业农村部正式受理。预计将于2026年第一季度开始I期临床试验。根据临床前试验结果，就疗效和安全性而言，依苏帕格鲁肽α在宠物糖尿病管理方面已取得积极进展，可为后续开展该药物相关的临床试验和注册申请提供合理依据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"1122862815","title":"银诺医药集团新兽药临床试验申请获农业农村部受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1122862815","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122862815?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:18","pubTimestamp":1770214693,"startTime":"0","endTime":"0","summary":"广州银诺医药集团有限公司宣布，其提交的一项新型兽用药品临床试验申请已获得农业农村部正式受理。该进展标志着公司在兽药研发领域取得重要突破，为后续产品管线拓展奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2608340873","title":"银诺医药-B创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2608340873","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608340873?lang=zh_cn&edition=full","pubTime":"2026-02-03 09:37","pubTimestamp":1770082653,"startTime":"0","endTime":"0","summary":"格隆汇2月3日丨银诺医药-B(02591.HK)跌1.6%，报28.3600港元，股价创历史新低，总市值129.55亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203094118a6cc38b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203094118a6cc38b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2607075633","title":"从入通大跌到“十字星”，低位整理的银诺医药-B(02591)变盘在即？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607075633","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607075633?lang=zh_cn&edition=full","pubTime":"2026-01-31 12:29","pubTimestamp":1769833791,"startTime":"0","endTime":"0","summary":"在过去的2025年，火热的港股IPO市场诞生了不少“明星IPO标的”，而在一众“明星”中，银诺医药-B依旧能凭借“港股机制B第一股”的身份从其中脱颖而出。银诺医药作为新规下发行第一股，暗盘暴涨超270%，市值超324亿港元，并凭此一举通过季度快速纳入机制成为恒生综合指数成份股，在去年12月8日获纳入港股通名单。1月27日，银诺医药的港股通持股比例仅剩0.27%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2607807571","title":"银诺医药-B01月30日遭主力抛售230.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607807571","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607807571?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:16","pubTimestamp":1769760967,"startTime":"0","endTime":"0","summary":"01月30日, 银诺医药-B股价跌5.28%，报收29.80元，成交金额4692.4万元，换手率0.37%，振幅8.65%，量比0.34。银诺医药-B今日主力资金净流出230.3万元，连续4日净流出，上一交易日主力净流出490.4万元。该股近5个交易日下跌5.25%，主力资金累计净流出4774.6万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出4730.0万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162713a468463c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162713a468463c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2605945483","title":"银诺医药-B01月21日主力净流入68.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2605945483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605945483?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:15","pubTimestamp":1768983337,"startTime":"0","endTime":"0","summary":"01月21日, 银诺医药-B股价涨1.17%，报收31.04元，成交金额687.1万元，换手率0.05%，振幅2.28%，量比0.72。银诺医药-B今日主力资金净流入68.0万元，上一交易日主力净流出0万元。该股近5个交易日下跌0.64%，主力资金累计净流入152.6万元；近20日主力资金累计净流入152.7万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121162717a444ba18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121162717a444ba18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2603785509","title":"银诺医药-B01月13日主力净流入147.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603785509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603785509?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:16","pubTimestamp":1768292170,"startTime":"0","endTime":"0","summary":"01月13日, 银诺医药-B股价涨2.38%，报收31.82元，成交金额1392.2万元，换手率0.10%，振幅6.37%，量比1.22。银诺医药-B今日主力资金净流入147.6万元，上一交易日主力净流出307.9万元。该股近5个交易日上涨3.12%，主力资金累计净流出308.5万元；近20日主力资金累计净流入393.3万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113163047a4bdf9fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113163047a4bdf9fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2602029326","title":"银诺医药-B01月09日主力净流出165.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2602029326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602029326?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:15","pubTimestamp":1767946551,"startTime":"0","endTime":"0","summary":"01月09日, 银诺医药-B股价跌2.64%，报收30.96元，成交金额1269.9万元，换手率0.10%，振幅5.28%，量比1.40。银诺医药-B今日主力资金净流出165.4万元，上一交易日主力净流入8.6万元。该股近5个交易日上涨1.97%，主力资金累计净流出34.2万元；近20日主力资金累计净流入63.4万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109162156a4af7115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109162156a4af7115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"2601767308","title":"银诺医药-B01月07日主力净流入8.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601767308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601767308?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:15","pubTimestamp":1767773757,"startTime":"0","endTime":"0","summary":"01月07日, 银诺医药-B股价涨1.82%，报收31.36元，成交金额1135.5万元，换手率0.09%，振幅3.44%，量比1.44。银诺医药-B今日主力资金净流入8.6万元，上一交易日主力净流出32.6万元。该股近5个交易日上涨0.97%，主力资金累计净流入122.6万元；近20日主力资金累计净流入243.8万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107162225a6fdcef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107162225a6fdcef4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"1193143611","title":"广州银诺医药（02591）2025年12月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1193143611","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193143611?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:42","pubTimestamp":1767688939,"startTime":"0","endTime":"0","summary":"广州银诺医药集团股份有限公司（02591）于2026年1月6日发布2025年12月股份变动月报表。报告期截至2025年12月31日，公司各类股份总数未发生变动。\n截至本月末，公司已发行H股420,285,370股，非上市股份36,533,979股；注册股本总额保持在人民币456,819,349元，较上月底无增减变化。本月未发生新增发行、回购、注销及库藏股活动，亦无股份期权或股权激励计划变动。\n公司表示将继续遵守香港联交所上市规则及相关法规。该公告由联席公司秘书金今签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"gpt_icon":0},{"id":"2601885889","title":"银诺医药-B01月05日主力净流入146.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601885889","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601885889?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:16","pubTimestamp":1767600973,"startTime":"0","endTime":"0","summary":"01月05日, 银诺医药-B股价涨1.84%，报收30.98元，成交金额1521.4万元，换手率0.12%，振幅4.73%，量比2.29。银诺医药-B今日主力资金净流入146.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌3.98%，主力资金累计净流入204.1万元；近20日主力资金累计净流入368.6万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162512a49e1cba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162512a49e1cba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2600508551","title":"银诺医药荣膺亚太代谢疾病药物开发卓越奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2600508551","media":"银诺医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600508551?lang=zh_cn&edition=full","pubTime":"2025-12-31 19:12","pubTimestamp":1767179550,"startTime":"0","endTime":"0","summary":"银诺医药荣获“2025年亚太代谢疾病药物开发卓越奖”，彰显银诺医药在GLP-1药物领域的国际影响力。银诺医药是全球第三家、亚洲第一家将人源、长效GLP-1受体激动剂推进至商业化阶段的公司。本次奖项由国际权威行业媒体《Life Science Review》亚太版评选发布。此次获奖是对依苏帕格鲁肽α创新价值和临床潜力的高度认可。银诺医药将持续以原创科技驱动高质量发展，为全球代谢疾病患者提供更优治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231214112a48ed3d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231214112a48ed3d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2593497421","title":"银诺医药-B荣获“格隆汇金格奖·年度卓越创新力IPO”奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2593497421","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593497421?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:27","pubTimestamp":1766492822,"startTime":"0","endTime":"0","summary":"格隆汇12月22日线上举办“科技赋能·资本破局”分享会。备受瞩目的卓越公司评选榜单隆重揭晓。其中，格隆汇“金格奖”年度卓越公司评选中，银诺医药-B(02591.HK)荣获“年度卓越创新力IPO”奖项。\r\n\r\n　　“年度卓越创新力IPO”奖项是对公司过去一年在产品创新、模式创新、组织创新等方面进行考量，旨在表彰以持续创新紧跟市场步伐，在模式与路径上获得优秀成果的新上市公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251223/31885620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02591"],"gpt_icon":0},{"id":"2592950361","title":"港股异动 | 银诺医药-B(02591)盘中涨超3% 依苏帕格鲁肽ɑ获国家基层糖尿病防治指南推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2592950361","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592950361?lang=zh_cn&edition=full","pubTime":"2025-12-17 11:00","pubTimestamp":1765940420,"startTime":"0","endTime":"0","summary":"消息面上，据银诺医药官微消息，在《\"健康中国2030\"规划纲要》推动糖尿病防治关口前移、提升创新药物可及性的战略部署下，中国原研首款超长效人源性GLP-1受体激动剂依苏帕格鲁肽α正式纳入2025版国家医保药品目录，适用于\"成人2型糖尿病患者的血糖控制\"，自2026年1月1日起正式执行。在《国家基层糖尿病防治管理指南 》中，依苏帕格鲁肽ɑ被列为注射类降糖药物的GLP-1RA周制剂，为基层医疗机构配备和使用该药提供了直接的政策与规范依据。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02591","BK1161"],"gpt_icon":0},{"id":"1150760712","title":"港股异动｜生物医药股上扬，药捷安康涨超17%，昭衍新药涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150760712","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150760712?lang=zh_cn&edition=full","pubTime":"2025-12-17 10:50","pubTimestamp":1765939813,"startTime":"0","endTime":"0","summary":"轩竹生物涨超5%，银诺医药涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"22a0e03e703ab82b83863db78ab69d04","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127","02575","02591","02617"],"gpt_icon":0},{"id":"1176090511","title":"一周港股牛熊榜 |  长飞光纤光缆周内飙34%，AI算力基建热潮推动光通信需求；轩竹生物周升28%，轩悦宁进入医保目录；第一拖拉机周升21%获高盛看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1176090511","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176090511?lang=zh_cn&edition=full","pubTime":"2025-12-12 18:12","pubTimestamp":1765534337,"startTime":"0","endTime":"0","summary":"高速光模块、光纤光缆及相关配套设备的需求随之水涨船高。$轩竹生物-B$ 本周累升28.11%，轩悦宁进入医保目录，两款肿瘤产品年内密集获批轩竹生物近日宣布，创新药轩悦宁首次纳入国家基本医保药品目录。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f31f9c4b7b746092dc00ca030c9a8d42","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一周港股牛熊榜 |  长飞光纤光缆周内飙34%，AI算力基建热潮推动光通信需求；轩竹生物周升28%，轩悦宁进...","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575","00108","HSCEI","09678","01072","06127","01618","02591","02643","HSTECH","HSI","00038","06869"],"gpt_icon":1},{"id":"1189663107","title":"港股综述 | 新股宝济药业涨近139%，图达通涨33%；黄金股、内房股走强，灵宝黄金涨超9%，万科企业涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189663107","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189663107?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:40","pubTimestamp":1765356031,"startTime":"0","endTime":"0","summary":"港股行情港股三大指数齐涨，恒生指数涨0.42%，恒生科技指数涨0.48%，国企指数涨0.20%。此外，今日两只新股上市，宝济药业-B首日上市涨138.82%，图达通首日上市涨33%。猪肉股涨幅居前，惠生国际涨超9%，万洲国际涨超5%。$石药集团$涨超3%，司美格鲁肽注射液第二项上市许可申请获受理。$灵宝黄金$涨超9%，拟斥资17.35亿元收购巴布亚新几内亚金矿权益。A股行情A股三大指数涨跌不一，截至收盘，沪指跌0.23%报3900点，深证成指涨0.29%，创业板指跌0.02%。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c285d9a76c27d3b07a8e1d710acacdec","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSI","02591","HSTECH","00815","09987"],"gpt_icon":0},{"id":"2590374400","title":"港股银诺医药-B拉升逾23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590374400","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590374400?lang=zh_cn&edition=full","pubTime":"2025-12-10 11:00","pubTimestamp":1765335658,"startTime":"0","endTime":"0","summary":"每经AI快讯，银诺医药-B(02591.HK)逆市拉升逾23%。截至发稿涨23.38%，报39.44港元，成交额7649.49万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512103587513597.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512103587513597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02591","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innogenpharm.com","stockEarnings":[{"period":"1week","weight":-0.0993},{"period":"1month","weight":-0.1441},{"period":"3month","weight":-0.1053},{"period":"6month","weight":0.4368},{"period":"ytd","weight":-0.124}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.2713},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广州银诺医药集团股份有限公司是一家主要从事医药产品的研发及商业化的中国投资控股公司。该公司主要从事商业化原研人源长效胰高血糖素样肽-1（GLP-1）受体激动剂。该公司致力于开发糖尿病和其他代谢性疾病的疗法。该公司的主要产品依苏帕格鲁肽α（商品名：怡诺轻）用于治疗2型糖尿病（T2D）。该公司的主要候选药物管线产品包括YN014、YN401、YN209、YN203和YN202。该公司主要在国内市场经营其业务。","exchange":"SEHK","name":"银诺医药-B","nameEN":"INNOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"银诺医药-B(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供银诺医药-B(02591)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"银诺医药-B,02591,银诺医药-B股票,银诺医药-B股票老虎,银诺医药-B股票老虎国际,银诺医药-B行情,银诺医药-B股票行情,银诺医药-B股价,银诺医药-B股市,银诺医药-B股票价格,银诺医药-B股票交易,银诺医药-B股票购买,银诺医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"银诺医药-B(02591)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供银诺医药-B(02591)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}